Table 4.
DAAs used to treat HCV in 2016 and their most common side effects
| DAAs and side effects |
|---|
| Sofosbuvir |
| Fatigue and headaches |
| Simeprevir |
| Fatigue,* headaches,* nausea,*† rash (including photosensitivity),† and pruritus† |
| Daclatasvir* |
| Fatigue, headaches, anemia, and nausea |
| Ombitasvir-paritaprevir-ritonavir, and dasabuvir |
| Fatigue, nausea,‡ pruritus,‡ other skin reactions (eg, rash, erythema, and eczema), insomnia,‡ and asthenia |
| Ledipasvir-sofosbuvir |
| Fatigue, headache, and asthenia |
| Elbasvir-grazoprevir |
| Fatigue, headache, nausea, and anemia‡ |
| Sofosbuvir-velpatasvir |
| Headache, fatigue, anemia,‡ nausea,‡ headache, insomnia,‡ and diarrhea‡ |
Most common adverse reactions reported in combination with sofosbuvir and ribavirin.
Most common adverse reactions reported with in combination with pegylated IFN-alfa and ribavirin.
Most common adverse reactions reported in combination with ribavirin.